Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Autoimmune lymphoproliferative syndrome type 2 is an autosomal dominant disorder caused by mutations of the CASP10 gene, associated with increased risk of Hodgkin and non-Hodgkin lymphomas.
Lymphoproliferative syndrome
|
||||
|
Autoimmune lymphoproliferative syndrome type 2
|
|||
|
|
CASP10
|
||
|
Lymphoproliferative syndrome 1
|
|||
|
|
X-linked lymphoproliferative syndrome 1
|
|||
|
|
X-linked lymphoproliferative syndrome 2
|
|||
|
|
|
|
|
| 1. |
Wang J et al. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. 
|
| 2. |
Zhu S et al. (2006) Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.
|
| 3. |
Sneller MC et al. (1997) Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
|
 |
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944 Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits |